Xconomy: Agenda: State of the Biotech Union

Agenda: State of the Biotech Union


		AGENDA
		.
	12:30 – 1:30	Registration & Networking
	1:30 – 1:40	Welcome & Introduction Jim Edwards, Publisher, Xconomy Alex Lash, Xconomy Aarif Khakoo, VP Research and San Francisco Site Head, Amgen
	1:40 – 2:10	The Promise and Reality of Gene Editing Jacob Corn, Scientific Director, Innovative Genomics Initiative, UC Berkeley Matthew Porteus, Associate Professor of Pediatrics, Stanford University Marcy Darnovsky, Executive Director, Center for Genomics and Society (Moderator)
	2:10 – 2:40	Biotech In The Network Era John Wilbanks, Chief Commons Officer, Sage Bionetworks
	2:40 – 3:10	Software Eats Bio Vijay Pande, General Partner, Andreessen Horowitz Alex Lash, Xconomy
	3:10 – 3:25	Wilbanks & Pande Answer Your Questions Vijay Pande, General Partner, Andreessen Horowitz John Wilbanks, Chief Commons Officer, Sage Bionetworks
	3:25 – 3:55	Networking Break
	3:55 – 4:20	Tackling Zika And Other Infectious Threats Nima Farzan, CEO, PaxVax Melanie Ott, Senior Investigator, Gladstone Institute of Virology and Immunology, UCSF Duncan MacCannell, CSO, OAMD, Centers for Disease Control and Prevention Alex Lash, Xconomy (Moderator)
	4:20 – 4:45	The Future Of The Cancer Moonshot Peter Kuhn, Dean’s Professor of Biological Sciences; Professor of Medicine and Engineering, USC
	4:45 – 5:15	Biotech In Trumpland: What Comes Next Laurent Fischer, CEO, Tobira Therapeutics Camille Samuels, Partner, Venrock Adams Dudley, Director, UCSF Center for Healthcare Value Jenny Rooke, Managing Director, 5 Prime Ventures Alex Lash, Xconomy (Moderator)
	5:15 – 6:30	Networking Reception

*Schedule is subject to change.

Register here.